This is filed to report after the mitraclip procedure, the atrial perforation had to be closed with an occulder.It was reported that this was a mitraclip procedure to treat mitral regurgitation (mr) with grade 4.One clip was implanted.After the procedure, bidirectional shunt with dominant left to right shunt and a small end-diastolic right to left shunt and cardiogenic shock occurred.An occluder device was placed at the end of the mitraclip procedure.Details are listed in the attached article, iatrogenic atrial septal defect following the mitraclip procedure: a state-of-the-art review.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record could not be performed as lot and part number was not provided.Based on the information available, a definitive cause for the reported patient effects could not be determined.However, patient effects of atrial perforation and cardiogenic shock are listed in the mitraclip instructions for use as known possible complications associated with mitraclip procedures.Additional therapy/ non-surgical treatment was a result of case-specific circumstances as an occluder device was placed at the end of the mitraclip procedure.Although a conclusive cause for the reported patient effects and the relationship to the device, if any, cannot be determined, there is no indication of a product issue with respect to manufacture, design or labeling.D1: brand name changed from unknown mitraclip to mitraclip® system steerable guide catheter d2.Product code changed from nkm to dra.D4.Catalog no.Changed from unk cds to unk sgc03.D6.Implant date removed.
|